医学分子生物学杂志 ›› 2025, Vol. 22 ›› Issue (3): 295-299.doi: 10.3870/j.issn.1672-8009.2025.03.014

• 综述 • 上一篇    下一篇

血管内皮细胞铁死亡在动脉粥样硬化中的研究进展 #br#

  

  1. 1山西医科大学第二临床医学院 太原市, 030000 2山西医科大学第二医院心血管内科 太原市, 030000
  • 出版日期:2025-05-31 发布日期:2025-06-12

Research Progress of Ferroptosis of Vascular Endothelial Cells in Atherosclerosis #br#

  1. 1Second Clinical College of Shanxi Medical University, Taiyuan, 030001, China 2Department of Cardiovascular Medicine, the Second Hospital of Shanxi Medical University, Taiyuan, 030001, China
  • Online:2025-05-31 Published:2025-06-12

摘要: 动脉粥样硬化 (atherosclerosis, AS) 是导致脑梗死冠状动脉粥样硬化性心脏病等心脑血管疾病的主要病理基础, 血管内皮细胞的异常死亡和功能障碍在其中发挥着重要作用铁死亡是 2012 年发现的一种新型程序性细胞死亡形式, 目前已有大量研究发现其在内皮细胞功能障碍及异常死亡导致 AS 的过程中发挥着重要作用文章综述了铁死亡的机制及血管内皮细胞铁死亡导致 AS 可能的机制, 同时总结了可能影响血管内皮细胞铁死亡的药物, 为临床上防治 AS 提供理论基础及研究方向

关键词: 血管内皮细胞, 铁死亡, 动脉粥样硬化

Abstract: Atherosclerosis is the main pathological basis for cerebral infarction, coronary arteryatherosclerotic heart disease and other cardiovascular and cerebrovascular diseases. The abnormal death and functional disorder of vascular endothelial cells play an important role in it. Ferroptosis is a novel type of programmed cell death discovered in 2012, and there have been many studies showing that it plays an important role in the functional disorder and abnormal death of endothelial cells leading to AS. This review summarizes the mechanisms of ferroptosis and the possible mechanisms by which vascular endothelial cell ferroptosis leads to AS, and the drugs that may affect endothelial cell ferroptosis, providing a theoretical basis and research direction for the prevention and treatment of AS in clinical practice.

Key words: vascular endothelial cells, ferroptosis, atherosclerosis

中图分类号: